UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 362

Sortiert nach

LRRK2 kinase in Parkinson's disease

Science (American Association for the Advancement of Science), 2018-04, Vol.360 (6384), p.36-37

2018

Volltextzugriff (PDF)

Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease

Current opinion in cell biology, 2020-04, Vol.63, p.102-113

2020

Volltextzugriff (PDF)

mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)

Biochemical journal, 2008-12, Vol.416 (3), p.375-385

2008

Volltextzugriff (PDF)

LKB1 and AMPK and the cancer-metabolism link - ten years after

BMC biology, 2013-04, Vol.11 (1), p.36-36, Article 36

2013

Volltextzugriff (PDF)

The selectivity of protein kinase inhibitors: a further update

Biochemical journal, 2007-12, Vol.408 (3), p.297-315

2007

Volltextzugriff (PDF)

Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase

The EMBO journal, 2018-01, Vol.37 (1), p.1-18

2018

Volltextzugriff (PDF)

Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation

Nature communications, 2017-10, Vol.8 (1), p.830-14, Article 830

2017

Volltextzugriff (PDF)

The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling

PloS one, 2012-06, Vol.7 (6), p.e39132

2012

Volltextzugriff (PDF)

Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors

Biochemical journal, 2016-09, Vol.473 (17), p.2671-2685

2016

Volltextzugriff (PDF)

Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis

eLife, 2017-11, Vol.6

2017

Volltextzugriff (PDF)

LRRK2 activation in idiopathic Parkinson's disease

Science translational medicine, 2018-07, Vol.10 (451)

2018

Volltextzugriff (PDF)

Structural Basis for Rab8a Recruitment of RILPL2 via LRRK2 Phosphorylation of Switch 2

Structure (London), 2020-04, Vol.28 (4), p.406-417.e6

2020

Volltextzugriff (PDF)

The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters

Science signaling, 2014-07, Vol.7 (334), p.re3

2014

Volltextzugriff (PDF)

Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites

Biochemical journal, 2021-01, Vol.478 (2), p.299-326

2021

Volltextzugriff (PDF)

PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition

Cancer cell, 2016-08, Vol.30 (2), p.229-242

2016

Volltextzugriff (PDF)

The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters

Biochemical journal, 2014-03, Vol.458 (3), p.559-573

2014

Volltextzugriff (PDF)

14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization

Biochemical journal, 2010-09, Vol.430 (3), p.393-404

2010

Volltextzugriff (PDF)

Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors

Biochemical journal, 2013-06, Vol.452 (3), p.499-508

2013

Volltextzugriff (PDF)

Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer

Cancer cell, 2013-03, Vol.23 (3), p.406-420

2013

Volltextzugriff (PDF)

A pathway for Parkinson's Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain

eLife, 2018-11, Vol.7

2018

Volltextzugriff (PDF)

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases

eLife, 2016-01, Vol.5

2016

Volltextzugriff (PDF)

Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase

Biochemical journal, 2014-11, Vol.463 (3), p.413-427

2014

Volltextzugriff (PDF)

Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells

Gastroenterology (New York, N.Y. 1943), 2012-06, Vol.142 (7), p.1504-1515.e3

2012

Volltextzugriff (PDF)

Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)

Biochemical journal, 2009-06, Vol.421 (1), p.29-42

2009

Volltextzugriff (PDF)

Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils

Biochemical journal, 2018-01, Vol.475 (1), p.23-44

2018

Volltextzugriff (PDF)

1 – 25 von 362

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(355)
Mit Volltextzugriff
(341)

Publikationsform

Artikel
(360)
Berichte
(2)

Sprache

Englisch
(361)
Japanisch
(137)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(262)
Life Sciences & Biomedicine
(236)
Humans
(201)
Animals
(172)
Biochemistry & Molecular Biology
(156)
Phosphorylation
(130)
Mice
(111)
Cell Biology
(89)
Protein-Serine-Threonine Kinases - Metabolism
(73)
Amino Acid Sequence
(72)
Mutation
(68)
Molecular Sequence Data
(67)
Cell Line
(61)
Signal Transduction
(57)
Protein Serine-Threonine Kinases - Metabolism
(51)
Proteins
(47)
Enzyme Activation
(46)
Kinases
(45)
Parkinson's Disease
(44)
Protein-Serine-Threonine Kinases - Genetics
(44)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

LRRK2 kinase in Parkinson's disease

Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease

mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)

LKB1 and AMPK and the cancer-metabolism link - ten years after

The selectivity of protein kinase inhibitors: a further update

Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase

Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation

The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling

Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors

Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis

LRRK2 activation in idiopathic Parkinson's disease

Structural Basis for Rab8a Recruitment of RILPL2 via LRRK2 Phosphorylation of Switch 2

The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters

Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites

PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition

The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters

14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization

Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors

Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer

A pathway for Parkinson's Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases

Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase

Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells

Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)

Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils

Suchergebnisse filtern